Protalix BioTherapeutics (PLX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Protalix BioTherapeutics (PLX) over the last 17 years, with Q3 2025 value amounting to -$7.8 million.
- Protalix BioTherapeutics' Other Gross PP&E Adjustments fell 3835.25% to -$7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.8 million, marking a year-over-year decrease of 3835.25%. This contributed to the annual value of $34.9 million for FY2024, which is 340.13% up from last year.
- Latest data reveals that Protalix BioTherapeutics reported Other Gross PP&E Adjustments of -$7.8 million as of Q3 2025, which was down 3835.25% from -$5.0 million recorded in Q2 2025.
- Protalix BioTherapeutics' 5-year Other Gross PP&E Adjustments high stood at $34.9 million for Q4 2024, and its period low was -$7.8 million during Q3 2025.
- Its 5-year average for Other Gross PP&E Adjustments is $2.7 million, with a median of -$5.2 million in 2025.
- Data for Protalix BioTherapeutics' Other Gross PP&E Adjustments shows a peak YoY increase of 1279.23% (in 2025) and a maximum YoY decrease of 3835.25% (in 2025) over the last 5 years.
- Protalix BioTherapeutics' Other Gross PP&E Adjustments (Quarter) stood at $32.8 million in 2021, then grew by 1.22% to $33.2 million in 2022, then rose by 1.81% to $33.8 million in 2023, then rose by 3.4% to $34.9 million in 2024, then plummeted by 122.38% to -$7.8 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$7.8 million for Q3 2025, versus -$5.0 million for Q2 2025 and -$5.2 million for Q1 2025.